The new model starts in July 2023. Practices will be required to take on two-sided risk right from the start.
Stuart Staggs
Advertisement
Articles by Stuart Staggs
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
HS patients on biosimilar adalimumab lose response faster than those on the original drug
2
Global MS analysis links disability burden to rising economic strain
3
CMS negotiates a 70% discount for Ozempic and Wegovy
4
New drug class shows promise for geographic atrophy
5
